These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2242521

  • 21. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN.
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [Abstract] [Full Text] [Related]

  • 22. Double-blind crossover comparison of the antianginal effects of nifedipine and isosorbide dinitrate in patients with exertional angina receiving propranolol.
    Morse JR, Nesto RW.
    J Am Coll Cardiol; 1985 Dec; 6(6):1395-401. PubMed ID: 4067121
    [Abstract] [Full Text] [Related]

  • 23. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G.
    J Cardiovasc Pharmacol; 1992 Dec; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [Abstract] [Full Text] [Related]

  • 24. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH.
    N Engl J Med; 1986 Jun 12; 314(24):1547-52. PubMed ID: 3520315
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W, Maul FD, Bussmann WD, Lang E, Hör G, Kaltenbach M.
    Eur Heart J; 1988 Feb 12; 9(2):149-58. PubMed ID: 3280317
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
    Hammermeister KE, Fairclough D, Emsermann CB, Hamman R, Ho M, Phibbs S, Plomondon M, Valuck R, West D, Steiner JF.
    Clin Ther; 2009 Mar 12; 31(3):632-43. PubMed ID: 19393854
    [Abstract] [Full Text] [Related]

  • 27. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R, Brügmann U, Reiniger G, Rudolph W.
    Herz; 1985 Jun 12; 10(3):163-71. PubMed ID: 3926613
    [Abstract] [Full Text] [Related]

  • 28. Combination therapy with isosorbide dinitrate: current status and the future.
    Schroeder JS.
    Am Heart J; 1985 Jul 12; 110(1 Pt 2):284-91. PubMed ID: 3893082
    [Abstract] [Full Text] [Related]

  • 29. Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine.
    Martsevich SYu, Koutishenko N, Metelitsa VI.
    Int J Cardiol; 1998 Apr 01; 64(2):137-44. PubMed ID: 9688432
    [Abstract] [Full Text] [Related]

  • 30. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG, Mir MA.
    Postgrad Med J; 1983 Apr 01; 59 Suppl 2():30-4. PubMed ID: 6136959
    [Abstract] [Full Text] [Related]

  • 31. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC, Chakraborty S, Mondal M, Bhandari B.
    J Assoc Physicians India; 1993 May 01; 41(5):269-71. PubMed ID: 8300456
    [Abstract] [Full Text] [Related]

  • 32. Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.
    Nesto RW, White HD, Wynne J, Holman BL, Antman EM.
    Am J Cardiol; 1987 Aug 01; 60(4):256-61. PubMed ID: 3618486
    [Abstract] [Full Text] [Related]

  • 33. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
    Thadani U, Jacob RG.
    Drugs Today (Barc); 2008 Dec 01; 44(12):925-37. PubMed ID: 19198701
    [Abstract] [Full Text] [Related]

  • 34. Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use.
    Danahy DT, Aronow WS.
    Circulation; 1977 Aug 01; 56(2):205-12. PubMed ID: 406098
    [Abstract] [Full Text] [Related]

  • 35. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
    Schartl M, Dougherty C, Rutsch W, Schmutzler H.
    Am Heart J; 1985 Mar 01; 109(3 Pt 2):649-53. PubMed ID: 3838401
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
    Angus DC, Linde-Zwirble WT, Tam SW, Ghali JK, Sabolinski ML, Villagra VG, Winkelmayer WC, Worcel M, African-American Heart Failure Trial (A-HeFT) Investigators.
    Circulation; 2005 Dec 13; 112(24):3745-53. PubMed ID: 16344404
    [Abstract] [Full Text] [Related]

  • 37. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
    Quyyumi AA, Crake T, Wright CM, Mockus LJ, Fox KM.
    Br Heart J; 1987 Jun 13; 57(6):505-11. PubMed ID: 3304367
    [Abstract] [Full Text] [Related]

  • 38. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
    Ziaeian B, Fonarow GC, Heidenreich PA.
    JACC Heart Fail; 2017 Sep 13; 5(9):632-639. PubMed ID: 28711446
    [Abstract] [Full Text] [Related]

  • 39. Concomitant calcium antagonist plus isosorbide dinitrate therapy for markedly active variant angina.
    Winniford MD, Gabliani G, Johnson SM, Mauritson DR, Fulton KL, Hillis LD.
    Am Heart J; 1984 Nov 13; 108(5):1269-73. PubMed ID: 6496286
    [Abstract] [Full Text] [Related]

  • 40. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
    Carmody MS, Anderson JR.
    Cardiol Rev; 2007 Nov 13; 15(1):46-53. PubMed ID: 17172884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.